Skip to product information
1 of 1

SURGE Pept

PT-141 10mg

PT-141 10mg

Regular price €44,95 EUR
Regular price Sale price €44,95 EUR
Sale Sold out
Taxes included.Shipping calculated at checkout.
Quantity

PT-141 10mg — Research Material

PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide investigated for its interaction with melanocortin receptors. It is structurally related to melanotan-II and is studied as a distinct melanocortin receptor agonist.

In controlled laboratory environments, PT-141 may be investigated in connection with melanocortin-receptor binding, receptor selectivity, intracellular signaling, neurological pathways, behavioral models, and structure–activity relationships.

Published research has examined bremelanotide in relation to melanocortin receptors involved in central nervous-system signaling. However, these findings should not be interpreted as establishing that this independently supplied research material enhances sexual desire, treats erectile dysfunction, improves sexual performance, affects pigmentation, or provides any therapeutic benefit in humans or animals.

Bremelanotide is also the active ingredient in the FDA-approved prescription product Vyleesi. Vyleesi is approved for certain premenopausal women with acquired, generalized hypoactive sexual desire disorder. It is not approved for men, for erectile dysfunction, for general sexual enhancement, or for improving sexual performance.

That approval applies only to the regulated Vyleesi drug product and does not extend to independently supplied PT-141 research materials. This product is not represented as Vyleesi, is not interchangeable with an FDA-approved pharmaceutical product, and has not been established as safe, effective, sterile, or suitable for administration.

References to dosing, injection timing, onset of effects, sildenafil use, erection duration, increased dopamine release, or treatment of sexual dysfunction have been omitted because such statements could imply clinical instructions, drug equivalence, or intended human use.

The terms PT-141, bremelanotide, bremelanotide acetate, and differently formulated or modified melanocortin peptides should not automatically be treated as interchangeable. Peptide sequence, salt form, purity, molecular identity, potency, and composition should be verified using batch-specific analytical documentation.

Research Use Only

FOR LABORATORY RESEARCH USE ONLY.

For use only by qualified laboratory professionals in controlled research environments.

Not for human or veterinary use.
Not for human consumption.
Not intended for injection, ingestion, inhalation, topical application, or administration to humans or animals.

Not intended for clinical, diagnostic, therapeutic, preventive, nutritional, cosmetic, body-composition, athletic-performance, sexual-performance, or household use.

Not intended for pharmaceutical compounding or for the preparation of any product intended for human or animal administration.

This product is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition, nor is it intended to affect the structure or function of the human or animal body.

This product is not Vyleesi and is not represented as equivalent or interchangeable with any FDA-approved bremelanotide product.

Handle, store, and dispose of this material in accordance with applicable laboratory safety procedures and all relevant federal, state, and local requirements.

View full details

Laboratory analysis

Batch SP-PT1-2608A
Chromatogram · illustration METHOD HPLC-UV 214nm · the measured curve for batch SP-PT1-2608A is in its certificate
main peak imp. imp. 02 46 8 min
≥99%
Release criterion
Independent laboratory
Tested before listing
Tied to your batch code
Full chromatogram on request
Verify this batch
Batch
SP-PT1-2608A
Method
HPLC-UV 214nm
Purity
≥99%
Form
Lyophilized
Availability
In stock
PT-141 10mg
€44,95